Skip to main content
Top
Published in: Medical Oncology 2/2009

01-06-2009 | Case Report

Primary extragastrointestinal stromal tumor of the transverse mesocolon without c-kit mutations but with PDGFRA mutations

Author: Tadashi Terada

Published in: Medical Oncology | Issue 2/2009

Login to get access

Abstract

The author reports a rare case of primary large cystic extragastrointestinal stromal tumor (eGIST) of the transverse mesocolon with genetic analyses of the c-kit and platelet-derived growth factor receptor-α (PDGFRA) genes. A 78-year-old man was found to have a large cystic tumor in the abdomen, and the tumor was resected. Grossly, the tumor was located in the transverse mesocolon, and cystic. Microscopically, the tumor consisted of epithelioid cells with atypia. Mitotic figures were noted in five of 50 high power fields. Immunohistochemically, the tumor cells were positive for KIT, CD34, PDGFRA, and vimentin, but negative for cytokeratins, neuron specific enolase, desmin, S100 protein, α-smooth muscle actin, p53 protein, HMB45, CD68, CEA, factor VIII-related antigen, chromogranin, and synaptophysin. Ki67 labeling was 5%. Genetically, the tumor showed a point mutation (GAC → GTC) at codon 842 of exon 18 of the PDGFRA gene. Exon 12 of the PDGFRA gene and exons 9, 11, 13, and 17 of the c-kit gene showed no mutations. No recurrence is noted 3 years after the operation. This case shows that eGIST may occur in the transverse mesocolon.
Literature
1.
2.
go back to reference Losota J, Miettinen M. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs). Semin Diagn Pathol. 2006;23:91–101.CrossRef Losota J, Miettinen M. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs). Semin Diagn Pathol. 2006;23:91–101.CrossRef
3.
go back to reference Miettinen M, Lasota J. Gastrointestinal stromal tumor: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130:1466–78.PubMed Miettinen M, Lasota J. Gastrointestinal stromal tumor: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130:1466–78.PubMed
4.
go back to reference Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumor. Science. 1998;279:577–80.CrossRefPubMed Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumor. Science. 1998;279:577–80.CrossRefPubMed
5.
go back to reference Hirota S, Ohashi A, Nishida T, Isozaki K, Kinoshita K, Shinomura Y, et al. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumor. Gastroenterology. 2003;125:660–7.CrossRefPubMed Hirota S, Ohashi A, Nishida T, Isozaki K, Kinoshita K, Shinomura Y, et al. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumor. Gastroenterology. 2003;125:660–7.CrossRefPubMed
6.
go back to reference Hu X, Forster J, Damajanov I. Primary malignant gastrointestinal stromal tumor of the liver. Arch Pathol Lab Med. 2003;127:1606–8.PubMed Hu X, Forster J, Damajanov I. Primary malignant gastrointestinal stromal tumor of the liver. Arch Pathol Lab Med. 2003;127:1606–8.PubMed
7.
go back to reference Mendoza-Marin M, Hoang MP, Albores-Saavedra J. Malignant stromal tumor of the gall bladder with interstitial cells of Cajal phenotype. Arch Pathol Lab Med. 2002;126:481–2.PubMed Mendoza-Marin M, Hoang MP, Albores-Saavedra J. Malignant stromal tumor of the gall bladder with interstitial cells of Cajal phenotype. Arch Pathol Lab Med. 2002;126:481–2.PubMed
8.
go back to reference Ortiz-Hidalgo C, de Leon Borjorge B, Albores-Saavedra J. Stromal tumor of the gall bladder with phenotype of interstitial cells of Cajal: a previously unrecognized neoplasm. Am J Surg Pathol. 2000;24:1420–3.CrossRefPubMed Ortiz-Hidalgo C, de Leon Borjorge B, Albores-Saavedra J. Stromal tumor of the gall bladder with phenotype of interstitial cells of Cajal: a previously unrecognized neoplasm. Am J Surg Pathol. 2000;24:1420–3.CrossRefPubMed
9.
go back to reference Yamaura K, Kato M, Miyazawa M, Haba Y, Muramatsu A, Miyata K, et al. Stromal tumor of the pancreas with expression of c-kit protein: report of a case. J Gastroenterol Hepatol. 2004;19:467–70.CrossRefPubMed Yamaura K, Kato M, Miyazawa M, Haba Y, Muramatsu A, Miyata K, et al. Stromal tumor of the pancreas with expression of c-kit protein: report of a case. J Gastroenterol Hepatol. 2004;19:467–70.CrossRefPubMed
10.
go back to reference Daum O, Klecka J, Ferda J, Treska V, Vanecek T, Sima R, et al. Gastrointestinal stromal tumor of the pancreas: case report with documentation of KIT gene mutations. Virchows Archiv. 2005;446:470–2.CrossRefPubMed Daum O, Klecka J, Ferda J, Treska V, Vanecek T, Sima R, et al. Gastrointestinal stromal tumor of the pancreas: case report with documentation of KIT gene mutations. Virchows Archiv. 2005;446:470–2.CrossRefPubMed
11.
go back to reference Miettinen M, Monihan JM, Sarlomo-Rikala M, Kovatich AJ, Carr NJ, Emory TS, et al. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathological and immunohistochemical study of 26 cases. Am J Surg Pathol. 1999;23:1109–18.CrossRefPubMed Miettinen M, Monihan JM, Sarlomo-Rikala M, Kovatich AJ, Carr NJ, Emory TS, et al. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathological and immunohistochemical study of 26 cases. Am J Surg Pathol. 1999;23:1109–18.CrossRefPubMed
12.
go back to reference Jakobs K, Gheldere CD, Vanclooster P. A ruptured gastrointestinal stromal tumor of the transverse colon: a case report. Acta Chir Belg. 2006;106:218–21. Jakobs K, Gheldere CD, Vanclooster P. A ruptured gastrointestinal stromal tumor of the transverse colon: a case report. Acta Chir Belg. 2006;106:218–21.
13.
go back to reference Paparelli C, Cavallaro G, Basso L, Polistena A, Mingazzini P, De Toma G. Giant GIST of the mesocolon, report of a case. Minerva Chir. 2006;61:537–40.PubMed Paparelli C, Cavallaro G, Basso L, Polistena A, Mingazzini P, De Toma G. Giant GIST of the mesocolon, report of a case. Minerva Chir. 2006;61:537–40.PubMed
14.
go back to reference Terada T, Kawaguchi M, Furukawa K, Sekido Y, Osamura Y. Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int. 2002;52:740–6.CrossRefPubMed Terada T, Kawaguchi M, Furukawa K, Sekido Y, Osamura Y. Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int. 2002;52:740–6.CrossRefPubMed
15.
go back to reference Terada T, Kawaguchi M. Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med. 2005;271:271–5.CrossRef Terada T, Kawaguchi M. Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med. 2005;271:271–5.CrossRef
16.
go back to reference Terada T (2008). Gastrointestinal stromal tumor of the uterus: a case report with genetic analyses of c-kit and PDGFRA genes. Int J Gynecol Oncol (in press). Terada T (2008). Gastrointestinal stromal tumor of the uterus: a case report with genetic analyses of c-kit and PDGFRA genes. Int J Gynecol Oncol (in press).
17.
go back to reference Kim JH, Boo YJ, Jung CW, Park SS, Kim SJ, Mok YJ, et al. Multiple malignant extragastrointestinal stromal tumors of the greater omentum and results of immunohistochemistry and mutation analysis: a case report. World J Gastroenterol. 2007;13:3392–5.PubMed Kim JH, Boo YJ, Jung CW, Park SS, Kim SJ, Mok YJ, et al. Multiple malignant extragastrointestinal stromal tumors of the greater omentum and results of immunohistochemistry and mutation analysis: a case report. World J Gastroenterol. 2007;13:3392–5.PubMed
18.
go back to reference Yamamoto H, Oda Y, Kawagichi K, Nakamura N, Takahira T, Tamiya S, et al. c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue). Am J Surg Pathol. 2004;28:479–88.CrossRefPubMed Yamamoto H, Oda Y, Kawagichi K, Nakamura N, Takahira T, Tamiya S, et al. c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue). Am J Surg Pathol. 2004;28:479–88.CrossRefPubMed
19.
go back to reference Dow N, Giblen G, Sobin LS, Miettinen M. Gastrointestinal stromal tumors: differential diagnosis. Semin Diagn Pathol. 2006;23:111–9.CrossRefPubMed Dow N, Giblen G, Sobin LS, Miettinen M. Gastrointestinal stromal tumors: differential diagnosis. Semin Diagn Pathol. 2006;23:111–9.CrossRefPubMed
20.
go back to reference Ciontea SM, Radu E, Regalia T, Ceafalan L, Cretoiu D, Gherghiceanu M, et al. C-kit immunopositive interstitial cells (Cajal-type) in human myometrium. J Cell Mol Med. 2005;9:407–20.CrossRefPubMed Ciontea SM, Radu E, Regalia T, Ceafalan L, Cretoiu D, Gherghiceanu M, et al. C-kit immunopositive interstitial cells (Cajal-type) in human myometrium. J Cell Mol Med. 2005;9:407–20.CrossRefPubMed
21.
go back to reference Huizinga JD, Faussone-Pellegrini MS. About the presence of interstitial cells of Cajal outside the musculature of the gastrointestinal tract. J Cell Mol Med. 2005;9:468–73.CrossRefPubMed Huizinga JD, Faussone-Pellegrini MS. About the presence of interstitial cells of Cajal outside the musculature of the gastrointestinal tract. J Cell Mol Med. 2005;9:468–73.CrossRefPubMed
22.
go back to reference Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB–1 grade. Hum Pathol. 2002;33:669–76.CrossRefPubMed Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB–1 grade. Hum Pathol. 2002;33:669–76.CrossRefPubMed
23.
go back to reference Sakurai S, Hishima T, Takazawa Y, Sano T, Nakajima T, Saito K, et al. Gastrointestinal stromal tumor and KIT-positive mesenchymal cells in the omentum. Pathol Int. 2001;51:524–31.CrossRefPubMed Sakurai S, Hishima T, Takazawa Y, Sano T, Nakajima T, Saito K, et al. Gastrointestinal stromal tumor and KIT-positive mesenchymal cells in the omentum. Pathol Int. 2001;51:524–31.CrossRefPubMed
24.
go back to reference Min KW, Leabu M. Interstitial cells of Cajal (ICC) and gastrointestinal stromal tumor (GIST): facts, speculation, and myths. J Cell Mol Med. 2006;10:995–1013.CrossRefPubMed Min KW, Leabu M. Interstitial cells of Cajal (ICC) and gastrointestinal stromal tumor (GIST): facts, speculation, and myths. J Cell Mol Med. 2006;10:995–1013.CrossRefPubMed
25.
go back to reference Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical and molecular study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29:52–68.CrossRefPubMed Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical and molecular study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29:52–68.CrossRefPubMed
26.
go back to reference Singer S, Rubin BP, Lux ML, Chen CJ, Demetri GD, Fletcher JA. Prognostic value of KIT mutation type, mitotic activity and histological subtype in gastrointestinal stromal tumor. J Clin Oncol. 2002;20:3898–905.CrossRefPubMed Singer S, Rubin BP, Lux ML, Chen CJ, Demetri GD, Fletcher JA. Prognostic value of KIT mutation type, mitotic activity and histological subtype in gastrointestinal stromal tumor. J Clin Oncol. 2002;20:3898–905.CrossRefPubMed
Metadata
Title
Primary extragastrointestinal stromal tumor of the transverse mesocolon without c-kit mutations but with PDGFRA mutations
Author
Tadashi Terada
Publication date
01-06-2009
Publisher
Humana Press Inc
Published in
Medical Oncology / Issue 2/2009
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-008-9092-9

Other articles of this Issue 2/2009

Medical Oncology 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.